Beta-glucan, extracted from oat, enhances disease resistance against bacterial and parasitic infections

Area of Science:

• Immunology
• Microbiology
• Nutritional Science

Background:

• Bacterial and parasitic infections pose significant health challenges.
• Immune-modulating compounds like beta-glucans are explored for their therapeutic potential.
• Staphylococcus aureus and Eimeria vermiformis are common pathogens with varying infection mechanisms.

Purpose of the Study:

• To investigate the immunomodulatory effects of oat beta-glucan.
• To assess the efficacy of beta-glucan in enhancing resistance to Staphylococcus aureus and Eimeria vermiformis infections in mice.
• To elucidate the mechanisms underlying beta-glucan-mediated immune enhancement.

Main Methods:

• In vitro studies with isolated macrophages to evaluate phagocytic activity.
• In vivo experiments in mice challenged with S. aureus and E. vermiformis.
• Measurement of fecal oocyst shedding, antibody levels, and cytokine production (IFN-gamma).
• Analysis of lymphocyte populations (Thy 1.2(+), CD4(+), CD8(+)) in lymphoid tissues.

Main Results:

• Beta-glucan significantly enhanced macrophage phagocytic activity in vitro.
• Mice treated with beta-glucan showed significant protection against S. aureus challenge.
• Beta-glucan treatment reduced E. vermiformis fecal oocyst shedding and shortened the patency period.
• Increased antigen-specific antibody levels and splenic IFN-gamma-secreting cells were observed in beta-glucan-treated mice.
• Alterations in lymphocyte populations within mesenteric lymph nodes and Peyer's patches were noted.

Conclusions:

• Oat beta-glucan administration, both orally and parenterally, enhances resistance to S. aureus and E. vermiformis infections in mice.
• Beta-glucan modulates innate and adaptive immune responses, including phagocytosis, antibody production, and cellular immunity.
• These findings suggest beta-glucan as a potential natural immunomodulator for preventing or treating infections.